ERS Genomics signs CRISPR license agreement with Otsuka

Pharma Times

License grants Otsuka access to CRISPR/Cas9 genome editing technology

ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical

BioTech 365

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ignis Health licenses telehealth roadmap from the Medical University of South Carolina

Scienmag

Technology and Engineering Biotechnology Health Care Systems/Services Health Professionals Information Management/Tracking Systems Licenses/Patents Management Science/Operations Research Medicine/Health Technology Transfer Telecommunications

Lilly adds to pain pipeline with Asahi Kasei licensing deal

Pharma Phorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement

BioTech 365

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

Avacta Announces License Agreement With POINT Biopharma Inc.

BioTech 365

Avacta Announces License Agreement With POINT Biopharma Inc. Avacta Announces License Agreement With POINT Biopharma Inc.

How Different Crimes Can Affect Your Nursing License in Georgia

Pharma Mirror

But, you are finally here about to get your nursing license in the state of Georgia. When applying for a nursing license or getting your old one renewed, you might face some trouble if the background check doesn’t show up clean.

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

Pure Extracts Submits Application to Health Canada for Sales License

BioTech 365

Pure Extracts Submits Application to Health Canada for Sales License Pure Extracts Submits Application to Health Canada for Sales License VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure … Continue reading → GlobeNewswire

Sales 40

CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration

BioTech 365

ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips

BioTech 365

Announces License and Research Agreement with Philips ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022 IRVINE, Calif., ClearPoint Neuro, Inc. 18, 2021 … Continue reading → GlobeNewswire

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

BioTech 365

DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand

BioTech 365

DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand PARIS & SOUTH SAN FRANCISCO, Calif.–(BUSINESS

DNA 52

An Opportune Time to Update Medical Licensing

JAMA Internal Medicine

This Viewpoint discusses ways in which state medical licensing regulations can be modified to allow wider adoption of telemedicine by practitioners and to increase access for patients

PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN TAIWAN

BioTech 365

PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN TAIWAN – EUR 1.1 DGAP-News: PAION AG / Key word(s): Miscellaneous 05.03.2021 / 09:00 The issuer is solely responsible for the content of this announcement. million … Continue reading → EQS Newsfeed

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

Pharma Phorum

ImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from UK biotech iosBio. The post Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech appeared first on.

Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major swine indication

BioTech 365

Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major swine indication Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major swine indication PRESS RELEASE Algenex and Virbac sign international commercial licensing agreement … Continue reading → GlobeNewswire

Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine

BioTech 365

Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine — Deal provides nonexclusive access to Genevant’s leading LNP technology for use in Gritstone’s self-amplifying RNA COVID-19 vaccine program; NIH-sponsored Phase … Continue reading → GlobeNewswire

RNA 40

Renew Biopharma Announces Licensing Agreement with Hypercann Agrogenetics to Employ Proprietary Enzymes for Improved Varieties of Hemp

BioTech 365

Renew Biopharma Announces Licensing Agreement with Hypercann Agrogenetics to Employ Proprietary Enzymes for Improved Varieties of Hemp Renew Biopharma Announces Licensing Agreement with Hypercann Agrogenetics to Employ Proprietary Enzymes for Improved Varieties of Hemp SAN DIEGO–(BUSINESS WIRE)–#CBD–Renew Biopharma Inc.,

EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen

The Pharma Data

13, 2021 /PRNewswire/ — EVOQ Therapeutics today announced a license and collaboration agreement with Amgen for the discovery and development of novel drugs for autoimmune disorders. EVOQ Therapeutics today announced a license and collaboration agreement with Amgen.

Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin®

BioTech 365

AstraZeneca forges licensing agreement with Redx Pharma

The Pharma Data

AstraZeneca has signed a licensing deal with UK-based biotech company Redx Pharma for its fibrotic disease candidate RXC006. AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset.

GC Pharma Submits Biologics License Application to US FDA for Immune Globulin ‘GC5107’

BioTech 365

GC Pharma Submits Biologics License Application to US FDA for Immune Globulin ‘GC5107’ GC Pharma Submits Biologics License Application to US FDA for Immune Globulin ‘GC5107’ – Submission for entering the world’s largest US marketplace YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma … Continue reading → Business Wire

Cytiva licenses Allen Institute’s advanced machine learning technology

Scienmag

Strategic license to advance the field of 3D and live cell imaging Credit: Allen Institute Cytiva and the Allen Institute have entered into a license agreement to integrate the Allen Institute’s machine learning technology with Cytiva’s microscopy and image analysis systems to advance the development of cell imaging innovations.

Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists

BioTech 365

Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists … Continue reading → Business Wire

Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston

BioTech 365

Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston NEW YORK–(BUSINESS WIRE)–Columbia Care Inc.

AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development

BioTech 365

AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development SAN DIEGO–(BUSINESS WIRE)–AvantGen, Inc.,

Avacta Announces License Agreement With POINT Biopharma Inc.

The Pharma Data

The agreement provides POINT with an exclusive license to the pre|CISION technology for use in the first radiopharmaceutical prodrug the company intends to develop, and a non-exclusive license to the pre|CISION platform for the development of a broader pipeline of FAP-activated radiopharmaceuticals.

Foundation Medicine Enters into Patent Licensing and Technology Agreement with TwinStrand Biosciences

BioTech 365

Foundation Medicine Enters into Patent Licensing and Technology Agreement with TwinStrand Biosciences Foundation Medicine Enters into Patent Licensing and Technology Agreement with TwinStrand Biosciences CAMBRIDGE, Mass.–(BUSINESS

X-Chem Enters into Multitarget Oncology Discovery Research Collaboration and License Agreement with Genentech

BioTech 365

X-Chem Enters into Multitarget Oncology Discovery Research Collaboration and License Agreement with Genentech X-Chem Enters into Multitarget Oncology Discovery Research Collaboration and License Agreement with Genentech Collaboration Includes Licensing of Preclinical Small Molecule Program WALTHAM, Mass.–(BUSINESS

BioSpace Global Roundup: Cevec Licenses AAV Program to Biogen

The Pharma Data

Germany-based Cevec Pharmaceuticals GmbH signed a licensing agreement with Biogen for the use of its proprietary ELEVECTA Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications.

Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications

BioTech 365

Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG-3777 ANG-3777 is a … Continue reading → Business Wire

Gilead licenses Jounce immunotherapy for $800m

Pharma Phorum

billion collaboration deal with Jounce, under which both companies would develop multiple cancer immunotherapies, but in the wake of Celgene’s acquisition by BMS the company restructured the deal to instead commit up to $530 million for global licensing rights to another Jounce drug, JTX-8064.

Valor Compounding Pharmacy™ is Committed to Serving More Patients with Licenses in 14 States

BioTech 365

Valor Compounding Pharmacy™ is Committed to Serving More Patients with Licenses in 14 States Valor Compounding Pharmacy™ is Committed to Serving More Patients with Licenses in 14 States Valor Compounding Pharmacy makes custom medications and delivers with free 2-day shipping … Continue reading → Business Wire

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa

BioTech 365

Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa TYG100 utilizes proprietary S-TIR™ technology platform enabling specific B cell … Continue reading → GlobeNewswireApollomics, Inc.

Study questions whether pubs can effectively prevent COVID-19 transmission risk

Scienmag

Credit: University of Stirling A new first-of-its-kind study has questioned whether pub operators can effectively and consistently prevent COVID-19 transmission – after researchers observed risks arising in licensed premises last summer.

Artiva Biotherapeutics Announces Exclusive Worldwide Collaboration and License Agreement with Merck to Develop Candidate CAR-NK Cell Therapies

BioTech 365

Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA

BioTech 365

Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA Omeros Submits its Biologics License Application to U.S.

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide

BioTech 365

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide CAMBRIDGE, Mass.,

AstraZeneca forges licensing agreement with Redx Pharma

Pharma Times

AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset

Modernize Medical Licensing, and Credentialing, Too

JAMA Internal Medicine

Because physician licensure is by state, states had to waive this requirement to hire physicians licensed in other states. The coronavirus disease 2019 (COVID-19) pandemic has revealed how ill prepared our current state licensure and individual hospital credentialing procedures are to respond to a crisis, which requires hiring more physicians. In the past year, various states have been in desperate need of additional physicians to care for critically ill patients.

Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute

BioTech 365

Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute CAMBRIDGE, Mass.–(BUSINESS